Cysteine Cathepsins: Potential Applications in Diagnostics and Therapy of Malignant Tumors
- PMID: 31509726
- DOI: 10.1134/S000629791907006X
Cysteine Cathepsins: Potential Applications in Diagnostics and Therapy of Malignant Tumors
Abstract
Cysteine cathepsins are proteolytic enzymes involved in protein degradation in lysosomes and endosomes. Cysteine cathepsins have been also found in the tumor microenvironment during carcinogenesis, where they are implicated in proliferation, invasion and metastasis of tumor cells through the degradation of extracellular matrix, suppression of cell-cell interactions, and promotion of angiogenesis. In this regard, cathepsins can have a diagnostic value and represent promising targets for antitumor drugs aimed at inhibition of these proteases. Moreover, cysteine cathepsins can be used as activators of novel targeted therapeutic agents. This review summarizes recent discovered roles of cysteine cathepsins in carcinogenesis and discusses new trends in cancer therapy and diagnostics using cysteine cathepsins as markers, targets, or activators.
Similar articles
-
Cysteine cathepsins: From diagnosis to targeted therapy of cancer.Biochimie. 2024 Nov;226:10-28. doi: 10.1016/j.biochi.2024.09.001. Epub 2024 Sep 6. Biochimie. 2024. PMID: 39245316 Review.
-
Tumor cell- and microenvironment-specific roles of cysteine cathepsins in mouse models of human cancers.Biochim Biophys Acta Proteins Proteom. 2020 Jul;1868(7):140423. doi: 10.1016/j.bbapap.2020.140423. Epub 2020 Apr 2. Biochim Biophys Acta Proteins Proteom. 2020. PMID: 32247787 Review.
-
Cysteine cathepsins and their potential in clinical therapy and biomarker discovery.Proteomics Clin Appl. 2014 Jun;8(5-6):416-26. doi: 10.1002/prca.201300085. Epub 2014 Mar 24. Proteomics Clin Appl. 2014. PMID: 24470315 Review.
-
Cysteine Cathepsins and their Extracellular Roles: Shaping the Microenvironment.Cells. 2019 Mar 20;8(3):264. doi: 10.3390/cells8030264. Cells. 2019. PMID: 30897858 Free PMC article. Review.
-
Multiple roles for cysteine cathepsins in cancer.Cell Cycle. 2004 Dec;3(12):1516-619. doi: 10.4161/cc.3.12.1289. Epub 2004 Dec 6. Cell Cycle. 2004. PMID: 15539953 Review.
Cited by
-
Redox-Mediated Post-Translational Modifications of Proteolytic Enzymes and Their Role in Protease Functioning.Biomolecules. 2020 Apr 23;10(4):650. doi: 10.3390/biom10040650. Biomolecules. 2020. PMID: 32340246 Free PMC article. Review.
-
Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy.Drug Des Devel Ther. 2021 Jan 6;15:9-20. doi: 10.2147/DDDT.S285852. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33442233 Free PMC article. Review.
-
Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations.Pharmaceuticals (Basel). 2020 Sep 28;13(10):277. doi: 10.3390/ph13100277. Pharmaceuticals (Basel). 2020. PMID: 32998368 Free PMC article. Review.
-
Radiotherapy changes the salivary proteome in head and neck cancer patients: evaluation before, during, and after treatment.Clin Oral Investig. 2022 Jan;26(1):225-258. doi: 10.1007/s00784-021-03995-5. Epub 2021 May 29. Clin Oral Investig. 2022. PMID: 34052889
-
Cysteine Cathepsins Inhibition Affects Their Expression and Human Renal Cancer Cell Phenotype.Cancers (Basel). 2020 May 21;12(5):1310. doi: 10.3390/cancers12051310. Cancers (Basel). 2020. PMID: 32455715 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources